For many couples struggling with infertility, traditional treatments like in vitro fertilization (IVF) can be physically, emotionally, and financially taxing. However, advancements in fertility technology are offering a promising alternative: in vitro maturation (IVM). This innovative approach could provide a less painful, more affordable option for those seeking to build a family.
What Sets IVM Apart from IVF? IVM is emerging as a potential alternative to IVF, with the promise of reducing the time, cost, and side effects associated with traditional fertility treatments. While IVF requires hormone injections to mature eggs inside the body, IVM takes a different approach. Instead of stimulating the ovaries to produce mature eggs, IVM involves collecting immature eggs and maturing them in the lab, bypassing the need for extensive hormonal treatments. This process not only minimizes physical strain on the patient but also lowers treatment costs.
The first successful IVM procedure resulted in a baby born in South Korea in 1991. Although IVM historically led to fewer successful pregnancies compared to IVF, advances in technology are gradually improving the success rates. While IVF still boasts higher success rates overall, IVM presents a compelling option for certain patients.
Why IVM Might Be the Better Option for Some In addition to its gentler approach, IVM offers several advantages over traditional IVF. According to the Journal of Reproductive Biology and Endocrinology, IVM reduces the need for gonadotropin stimulation, lowering the risk of ovarian hyperstimulation syndrome (OHSS), a potentially dangerous side effect of IVF. With fewer injections, fewer clinic visits, and a shorter treatment timeline, IVM is not only less invasive but also more cost-effective.
Egg donors who have undergone multiple retrieval cycles may find IVM to be a viable option, as it can help improve the efficiency of the process. It is also an ideal treatment for “hyper-responders” — women whose ovaries naturally develop multiple follicles each month. Patients with conditions like polycystic ovary syndrome (PCOS) are often at higher risk for complications during IVF, making IVM a safer alternative in these cases.
A Lifeline for Cancer Patients For cancer patients whose fertility is at risk due to cancer treatments like chemotherapy, IVM may offer a quicker and less invasive solution. Many cancer patients lack the time needed for an extensive IVF cycle before beginning their treatment. IVM allows for a faster and less physically demanding process, which is crucial for those with limited time.
A Step Toward More Humane Fertility Treatments IVM’s benefits go beyond just the physical aspects; the treatment also holds promise for reducing the emotional and psychological toll that often accompanies fertility treatments. As more people turn to assisted reproductive technologies, there is growing recognition within the fertility industry of the need for treatments that are not only effective but also more humane. Dina Radenkovic, CEO of biotech company Gameto, emphasized the industry’s evolving understanding that fertility treatments should be compassionate and patient-centered.
Though IVM is not a one-size-fits-all solution, its potential to ease the burden of infertility treatment could revolutionize the field. With continuing advancements in research and technology, IVM could offer a new path to parenthood for many couples facing fertility challenges.
Related topics:
Study Identifies Molecular Drivers of Type 2 Diabetes in Women With Gestational Diabetes
Discontinuing Antidepressants During Pregnancy May Lower Risk of PPHN, Study Finds
